|
|
|
|
A Single-Tablet Regimen of Ledipasvir/Sofosbuvir for 12 Weeks in HCV Genotype 1- or 4-Infected Patients With HIV-1 Coinfection: the Phase 3 ION-4 Study
|
|
|
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
Curtis Cooper,1 Susanna Naggie,2 Michael Saag,3 Jenny Yang,4 Luisa Stamm,4 Philip Pang,4 John McHutchison,4 Douglas Dieterich,5 Mark Sulkowski6
1Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; 2Duke Clinical Research Institute, Durham, North Carolina, USA; 3The University of Alabama at Birmingham School of Medicine, Alabama, USA; 4Gilead Sciences, Inc., Foster City, California, USA; 5The Mount Sinai Hospital, New York, New York, USA; 6Johns Hopkins Medicine, Baltimore, Maryland, USA
|
|
|
|
|
|
|